Integrated analysis of gut metabolome, microbiome, and exfoliome data in an equine model of intestinal injury

Canaan Whitfield-Cargile, H Chung, Michelle C. Coleman, Noah D. Cohen, Ana M. Chamoun‐Emanuelli, Ivan Ivanov, Jennifer S. Goldsby, Laurie A. Davidson, Irina Gaynanova, Yifei Ni, Robert S. ChapkinMicrobiome 2024 · DOI

Abstract

Results of integrative analysis identified an important role for oxidative stress, and subsequent cell signaling responses, in a large animal model of GI inflammation. The computational approaches for combining non-invasive platforms for unbiased assessment of host GI responses (e.g., exfoliomics) with metabolomic and microbiota changes have broad application for the field of gastroenterology. Video Abstract.

Introduction

Understanding the complex "interactome" between a host and its gut microbiome is a primary goal in modern gastroenterology. While fecal samples provide easy access to microbial DNA, linking these microbial shifts to host cellular health typically requires invasive mucosal biopsies. This is particularly challenging in large animal models like horses and limits longitudinal studies in humans. This research presents a non-invasive "multi-omics" pipeline designed to bridge this gap, using an equine model of non-steroidal anti-inflammatory drug (NSAID)-induced intestinal injury to map the molecular cross-talk of the gut.

Methodology

The study utilized twenty horses, divided into a control group and an NSAID group treated with phenylbutazone. To capture a holistic view of the gut environment, the researchers integrated three non-invasive platforms:

  1. Microbiota: 16S rRNA gene sequencing of fecal samples to identify bacterial populations.
  2. Metabolome: Untargeted mass spectrometry to profile small-molecule metabolites.
  3. Exfoliome: A novel transcriptomic approach sequencing mRNA from host epithelial cells naturally shed (exfoliated) into the feces.

Advanced computational techniques were employed to filter and integrate these high-dimensional datasets. Multi-Group Sparse Discriminant Analysis (MGSDA) identified variables separating healthy from injured states, while Joint Association and Classification Analysis (JACA) served as the "bridge" to find highly correlated variables across all three datasets, ensuring biological coherence.

Results

The integrated analysis revealed a clear divergence in the gut environment following NSAID treatment. Principal Component Analysis (PCA) of the fecal metabolome demonstrated that by Day 10, the NSAID group had shifted significantly from its baseline and the control group, indicating a distinct metabolic signature of injury.

PCA of fecal metabolites showing distinct clustering of the NSAID Day 10 group compared to controls and baseline.

Key findings include:

  • High Multi-Omic Correlation: JACA identified a strong correlation (0.85) between the host exfoliome and the fecal metabolome, validating the link between host gene expression and the chemical environment of the gut.
  • Microbial Indicators: Sarcina was identified as a primary microbial discriminator, potentially linked to the colonization of gastric ulcers induced by the treatment.
  • Depletion of Beneficial Metabolites: Targeted analysis showed a significant drop in short-chain fatty acids (SCFAs), specifically butyrate (P=0.009) and propionate (P=0.002), in the NSAID-treated horses.

Discussion: The Oxidative Stress-ER Stress Axis

The study highlights the "exfoliome" as a powerful, non-invasive window into host tissue responses. A key metabolic marker, 2-hydroxynervonate (a very long-chain fatty acid), pointed toward peroxisomal dysfunction—a common result of oxidative stress.

This oxidative damage is likely compounded by the loss of butyrate-producing bacteria like Pseudobutyrivibrio. Butyrate serves as a critical antioxidant; its depletion leaves the gut lining vulnerable. The host response, captured via the exfoliome, indicated activation of the EIF2 signaling pathway, suggesting that cells are undergoing Endoplasmic Reticulum (ER) stress due to an accumulation of misfolded proteins. This "oxidative stress-ER stress" cycle appears to be a central driver of the inflammatory response to NSAIDs.

Conclusion and Future Directions

The researchers identified a "core signature" consisting of 8 metabolites, 4 bacterial genera, and 17 host genes that define NSAID-induced intestinal injury. While the study's sample size was modest (n=9 per group for fecal analysis), it successfully demonstrates that non-invasive multi-omics can mirror complex host-microbe interactions. Future work will aim to validate these mechanisms in human populations and explore whether the identified oxidative stress pathways are universal targets for treating enteropathy.

Summary updated

Abstract

Results of integrative analysis identified an important role for oxidative stress, and subsequent cell signaling responses, in a large animal model of GI inflammation. The computational approaches for combining non-invasive platforms for unbiased assessment of host GI responses (e.g., exfoliomics) with metabolomic and microbiota changes have broad application for the field of gastroenterology. Video Abstract.
BibTeX
@inproceedings{whitfieldcargile2024integrated,
  author = {Canaan Whitfield-Cargile and H Chung and Michelle C. Coleman and Noah D. Cohen and Ana M. Chamoun‐Emanuelli and Ivan Ivanov and Jennifer S. Goldsby and Laurie A. Davidson and Irina Gaynanova and Yifei Ni and Robert S. Chapkin},
  title = {{Integrated analysis of gut metabolome, microbiome, and exfoliome data in an equine model of intestinal injury}},
  booktitle = {Microbiome},
  year = {2024},
  doi = {10.1186/s40168-024-01785-1},
}
Figure